美国 · SEC FORM 4
Envoy Medical, Inc.
COCH · Nasdaq · CIK 0001840877 · Healthcare · Medical Devices
内部人信号
0 qualifying P purchase groups
当前 180 天评分窗口
1 同一窗口内观察到的 Form 4 交易行
0 sales · 1 期权、代扣税、授予、赠与或其他交易行
为什么没有活跃信号？
评分构成
活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。
为什么没有分数？
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。
卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
—
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后，这些模块才会启用。
信号历史
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2026-02-12 · Patel Mona Chetan.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 497,969
- 上期报告
- 529,130
- 日均成交量
- 62,533
- 回补天数
- 8.0
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-02-12 | TAYLOR GLEN A | 买入 (P) | Class A Common Stock | 18,750,000 | USD 0.40 | USD 7,500,000 | SEC 申报 ↗ |
| 2026-02-12 | Potashnick Robert | 买入 (P) | Class A Common Stock | 212,500 | USD 0.40 | USD 85,000 | SEC 申报 ↗ |
| 2026-02-12 | Patel Mona Chetan | 买入 (P) | Class A Common Stock | 312,500 | USD 0.40 | USD 125,000 | SEC 申报 ↗ |
| 2026-02-12 | Lucas Brent T. | 买入 (P) | Class A Common Stock | 62,500 | USD 0.40 | USD 25,000 | SEC 申报 ↗ |
| 2026-02-12 | Kantor Susan | 买入 (P) | Class A Common Stock | 96,150 | USD 0.40 | USD 38,460 | SEC 申报 ↗ |
| 2026-02-12 | BRYNELSEN CHARLES | 买入 (P) | Class A Common Stock | 1,000,000 | USD 0.40 | USD 400,000 | SEC 申报 ↗ |
| 2025-06-11 | Patel Mona Chetan | 买入 (P) | Class A Common Stock | 2,500 | USD 1.47 | USD 3,675 | SEC 申报 ↗ |
| 2025-06-06 | Patel Mona Chetan | 买入 (P) | Class A Common Stock | 10,000 | USD 1.46 | USD 14,600 | SEC 申报 ↗ |
| 2025-05-27 | BRYNELSEN CHARLES | 买入 (P) | Class A Common Stock | 35,000 | USD 1.65 | USD 57,750 | SEC 申报 ↗ |
| 2025-05-23 | BRYNELSEN CHARLES | 买入 (P) | Class A Common Stock | 13,000 | USD 1.64 | USD 21,320 | SEC 申报 ↗ |
| 2025-05-22 | BRYNELSEN CHARLES | 买入 (P) | Class A Common Stock | 2,000 | USD 1.68 | USD 3,360 | SEC 申报 ↗ |
| 2024-11-20 | Patel Mona Chetan | 买入 (P) | Class A Common Stock | 2,500 | USD 2.28 | USD 5,700 | SEC 申报 ↗ |
| 2024-09-11 | Patel Mona Chetan | 买入 (P) | Class A Common Stock | 4,000 | USD 3.33 | USD 13,320 | SEC 申报 ↗ |
| 2024-09-09 | Patel Mona Chetan | 买入 (P) | Class A Common Stock | 1,000 | USD 3.20 | USD 3,200 | SEC 申报 ↗ |
| 2023-11-21 | Lucas Brent T. | 买入 (P) | Class A Common Stock | 12,380 | USD 0.97 | USD 11,990 | SEC 申报 ↗ |
Form 4 申报证据
8 transaction lines in the latest 365-day window; 33 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-05-29 | Lucas Brent T. | 奖励／授予 (A) | Class A Common Stock | 32,856 | USD 0.60 | USD 19,714 | SEC 申报 ↗ |
| 2026-02-12 | TAYLOR GLEN A | 买入 (P) | Class A Common Stock | 18,750,000 | USD 0.40 | USD 7,500,000 | SEC 申报 ↗ |
| 2026-02-12 | Potashnick Robert | 买入 (P) | Class A Common Stock | 212,500 | USD 0.40 | USD 85,000 | SEC 申报 ↗ |
展开近期 Form 4 证据 (8 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-05-29 | Lucas Brent T. | 奖励／授予 (A) | Class A Common Stock | 32,856 | USD 0.60 | USD 19,714 | SEC 申报 ↗ |
| 2026-02-12 | TAYLOR GLEN A | 买入 (P) | Class A Common Stock | 18,750,000 | USD 0.40 | USD 7,500,000 | SEC 申报 ↗ |
| 2026-02-12 | Potashnick Robert | 买入 (P) | Class A Common Stock | 212,500 | USD 0.40 | USD 85,000 | SEC 申报 ↗ |
| 2026-02-12 | Patel Mona Chetan | 买入 (P) | Class A Common Stock | 312,500 | USD 0.40 | USD 125,000 | SEC 申报 ↗ |
| 2026-02-12 | Lucas Brent T. | 买入 (P) | Class A Common Stock | 62,500 | USD 0.40 | USD 25,000 | SEC 申报 ↗ |
| 2026-02-12 | Kantor Susan | 买入 (P) | Class A Common Stock | 96,150 | USD 0.40 | USD 38,460 | SEC 申报 ↗ |
| 2026-02-12 | BRYNELSEN CHARLES | 买入 (P) | Class A Common Stock | 1,000,000 | USD 0.40 | USD 400,000 | SEC 申报 ↗ |
| 2025-11-28 | Lucas Brent T. | 奖励／授予 (A) | Class A Common Stock | 18,105 | USD 0.71 | USD 12,855 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | COCH |
| CIK | 0001840877 |
| 行业 | Healthcare |
| 细分行业 | Medical Devices Yahoo Finance |
| SEC SIC | 3842 Orthopedic, Prosthetic & Surgical Appliances & Supplies |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 33 transaction lines from 2023-09-29 to 2026-05-29 16 P purchase lines · 0 S sale lines · 17 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.